NAMS

NewAmsterdam Pharma Company N.V.

Healthcare›Biotechnology|NASDAQ Capital Market|NL

Price

$32.99

Market Cap

$3.79B

Beta

0.07

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-50.61%

EPS Growth (YoY)+33.46%

Revenue CAGR 3Y-41.38%

P/E Ratio0.0

PEG Ratio—

FCF Yield-3.90%

Debt / Equity0.00

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for NAMS.